| Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry PM Machado, S Lawson-Tovey, A Strangfeld, EF Mateus, KL Hyrich, ... Annals of the rheumatic diseases 81 (5), 695-709, 2022 | 169 | 2022 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 110 | 2021 |
| Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study N Atas, B Armagan, E Bodakci, H Satis, A Sari, NSY Bilge, RB Salman, ... Rheumatology international 40 (1), 41-48, 2020 | 55 | 2020 |
| SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry J Liew, M Gianfrancesco, C Harrison, Z Izadi, S Rush, S Lawson-Tovey, ... RMD open 8 (1), e002187, 2022 | 41 | 2022 |
| SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases S Lawson-Tovey, KL Hyrich, L Gossec, A Strangfeld, L Carmona, ... Annals of the rheumatic diseases 81 (1), 145-150, 2022 | 35 | 2022 |
| Do ANCA‐associated vasculitides and IgG4‐related disease really overlap or not? A Erden, EC Bolek, KG Yardimci, L Kilic, SA Bilgen, O Karadag International Journal of Rheumatic Diseases 22 (10), 1926-1932, 2019 | 35 | 2019 |
| Predictors of persistent inflammation in familial Mediterranean fever and association with damage H Babaoglu, B Armagan, E Bodakci, H Satis, N Atas, A Sari, ... Rheumatology 60 (1), 333-339, 2021 | 29 | 2021 |
| Colchicine intolerance in FMF patients and primary obstacles for optimal dosing H Satiş, B Armağan, E Bodakci, N Ataş, A Sari, NŞY Bilge, D Yapar, ... Turkish Journal of Medical Sciences 50 (5), 1337-1343, 2020 | 20 | 2020 |
| Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ... Turkish Journal of Medical Sciences 51 (1), 297-308, 2021 | 14 | 2021 |
| Familial Mediterranean fever-associated infertility and underlying factors N Atas, B Armagan, E Bodakci, H Satis, A Sari, NSY Bilge, RB Salman, ... Clinical rheumatology 39, 255-261, 2020 | 13 | 2020 |
| Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: a real life experience L Kiliç, Ö Karadağ, A Erden, A Sari, B Armağan, GK Yardimci, ... Turkish Journal of Medical Sciences 50 (1), 31-36, 2020 | 11 | 2020 |
| Factors associated with damage in patients with familial Mediterranean fever H Babaoglu, B Armagan, E Bodakci, H Satis, N Atas, A Sari, NSY Bilge, ... Clin Exp Rheumatol 127 (5), 42-48, 2020 | 10 | 2020 |
| Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis B Armağan, L Kılıç, B Farisoğulları, GK Yardımcı, E Bilgin, EÇ Bölek, ... Rheumatology International 43 (1), 147-156, 2023 | 9 | 2023 |
| Coronary (peri)‐arteritis in patients with IgG4‐related disease: A case series from the Central Anatolia Region of Turkey GK Yardimci, S Ardali Duzgun, EC Bolek, L Kilic, U Canpolat, T Hazirolan, ... International journal of rheumatic diseases 24 (8), 1004-1013, 2021 | 8 | 2021 |
| CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum D Turgeon, V Bakowsky, C Baldwin, DA Cabral, M Clements-Baker, ... Rheumatology 62 (8), 2646-2651, 2023 | 6 | 2023 |
| Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease? B Farisogullari, MK Cuceoglu, H Oral, GK Yardimci, Y Bilginer, S Ozen, ... Internal and emergency medicine 17 (6), 1599-1608, 2022 | 6 | 2022 |
| Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry E Bilgin, B Farisoğulları, B Armağan, A Sarı, GK Yardımcı, EÇ Bölek, ... Clin Exp Rheumatol 6, 2019 | 6 | 2019 |
| AB0842 Drug survival and effectiveness of the first tnf inhibitors in patient with late onset spondylarthritis: treasure real-life results NA Kanıtez, S Kiraz, I Ertenli, O Küçükşahin, E Dalkılıç, C Bes, T Kaşifoğlu, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 1549-1549, 2018 | 6 | 2018 |
| Real-world data on MTX tolerance with regimens used in children versus adults U Kaya Akca, B Farisogullari, GK Yardimci, E Sag, E Atalay, ... Clinical Rheumatology 40, 5095-5102, 2021 | 5 | 2021 |
| Cognitive Status is Better in Older Adults under Colchicine Treatment: A Case-Control Study A Okyar Baş, GK Yardımcı, M Güner Oytun, S Ceylan, Z Kahyaoğlu, ... Experimental Aging Research 50 (1), 17-27, 2024 | 4 | 2024 |
